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Background: Functional constipation (FC) is a common functional gastrointestinal disorders (FGIDs) which has a
major impact on the quality of life. Acupuncture is widely used as an alternative and complementary medicine
(CAM) for FC, but the available evidence of its effectiveness is scarce. Therefore, we will perform a randomized
controlled trial to determine whether acupuncture improves symptom and quality of life in FC patients more
effectively than sham acupuncture or gastrointestinal prokinetic agent. This article will report the protocol of the trial.
Methods: The current trial is a multicenter, randomized, three-arm controlled study undergoing in China. About 243
people who aged from 18 to 65 years with FC will be recruited in this study. These participants will be randomly
allocated into three treatment groups, including electro-acupuncture (EA), Mosapride (M) and Mosapride & Sham
Electro-acupuncture (MS) groups in a 1:1:1 ratio. Both the EA and sham EA receives 16 sessions of needling at
Quchi (LI11) and Shangjuxu (ST37) during 4 weeks of treatment, and a follow-up period of 4 weeks. These groups
will be compared on the primary outcomes of the number of times of defecation at baseline and 2, 4, 8 weeks
after randomization. The secondary outcome measures include: stool consistency, intensity of defecating difficulty,
MOS item Short Form health survey (SF-36), Self-Rating Anxiety Scale (SAS), Self-rating Depression Scale (SDS), and
the validated Patient Assessment of Constipation Quality of Life (PAC-QOL). These outcomes are measured at baseline
and 2, 4 weeks after randomization, but SF-36 is measured at baseline and 4 weeks after randomization.
Discussion: This study will supply significant evidence for using acupuncture to treat FC, and will help us to observe
whether it is a therapeutic effect rather than a placebo effect.Background
Functional constipation (FC) is a common functional
gastrointestinal disorders (FGIDs), defined as infrequent
bowel movements, hard or lumpy stools, straining during
defecation that does not meet the IBS criteria [1]. Accord-
ing to the survey, about 12%-19% population in the US
and 14% in Asia suffer from the symptoms of functional
constipation [2-4]. As a major public health issue, functional
constipation negatively affects health-related quality of life
and is associated with substantial costs.
Usual care involves lifestyle modification such as dietary
changes and aerobic activities are recommended to help
in relieving symptoms but some studies have suggested
that the effect is not obviously [5,6]. In recent years,* Correspondence: chzheng2008@qq.com; gyhuang@tjh.tjmu.edu.cn
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unless otherwise stated.conventional treatments include gastrointestinal proki-
netic agent, enemas, osmotic and stimulant laxatives
has displayed a positive effect in functional constipation
therapy. However, the efficacy is limited and unwanted
side effects are induced with a long therapeutic course [7].
More and more people have focused on alternative and
complementary medicine (CAM) to look for a safe and
effective therapy for functional constipation in Western
countries [8]. Acupuncture as one of the most frequently
applied methods in Traditional Chinese Medicine (TCM),
which has a history of more than 3000 years in treating
functional constipation, has gained increased popularity.
Previous studies have shown that acupuncture may be
effective in the treatment of functional constipation but
have not provided conclusive evidence of its efficacy. An
appropriate trial protocol is needed to investigate the
effectiveness of acupuncture for functional constipation.
Thus we designed a multicenter randomized controlledThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ture for FC. Meanwhile, we aim to address whether acu-




This is a multicenter randomized controlled, three-arm
trial enrolling both men and women with functional con-
stipation in China. This study will be conducted at Tongji
Hospital affiliated to Tongji Medical College, Huazhong
University of Science and Technology; Hubei Provincial
Hospital of TCM; Hospital of Huazhong University of
Science and Technology. Tongji Hospital is the centralPatients with functio
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Figure 1 Trial flow chart.structure of the study. The participants will be allocated
through complete randomization in a 1:1:1 ratio. The
randomization sequence will be generated using R2.0 soft-
ware. A designated researcher will prepare the assignments
in opaque envelopes in sequence. The acupuncturists will
only know of the group assignment prior to the treatment.
This trial is financed by the National Basic Research Pro-
gram (No. 2011CB505203). The research protocol has
been approved by the Clinical Trial Ethics Committee of
Tongji Medical College, Huazhong University of Science
and Technology (approval no. FWA00007304) and regis-
tered on the ClinicalTrials.gov protocol registration system
(http://clinicaltrials.gov/ct2/show/NCT01781897, Clinical-
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screening period of 1 week, a treatment period of 4 weeks,
and a follow-up period of 4 weeks. Constipation diaries are
required to record at least 1 week before randomization as
baseline data and this course will be continue to 8 weeks if
they are eligible for this trial. All outcomes are assessed
at baseline and 2, 4, and 8 weeks after randomization
according to the diaries. A total of 16 sessions of acu-
puncture treatment will performed over a period of 4 weeks
and each session will last 30 min after randomization. Five
times a week in the first 2 weeks and three times a week
in the last 2 weeks (Figure 1).Patients
Study population
Our study will include patients with chronic functional
constipation. To ensure the precision of results of this
trial, patients who meet the following eligible criteria will
be included in this study.Inclusion criteria
Men and women between 18 and 65 years old who met
the Rome III Criteria for functional constipation (FC),
including two or more of the following symptoms for at
least 12 weeks during the 6 months before enrolling the
study: (1) straining during at least 25% of defecations;
(2) lumpy or hard stools during at least 25% of defeca-
tions; (3) sensation of incomplete evacuation during at
least 25% of defecations. (4) Sensation of anorectal ob-
struction or blockage for at least 25% of defecation; (5)
Manual maneuvers to facilitate at least 25% of defecation
(e.g. support of fingers or pelvic floor); (6) fewer than
three spontaneous bowel movements (SBMs) per week.
And (1) loose stools are rarely present without the use
of laxatives, (2) insufficient criteria for irritable bowel
syndrome are necessary. Meanwhile we must confirm all
the participants did not use any gastrointestinal drugs at
least 1 week before randomization and never joined any
other trial in progress. They signed a written consent
form and volunteered to finish the whole study.Exclusion criteria
Patients with any of the following conditions will be ex-
cluded: constipation caused by other endocrine, metabolic,
nervous or postoperative diseases or drugs; irritable bowel
syndrome (IBS) and inflammatory bowel disease or other
structural bowel diseases; psychiatric diseases and cog-
nitive dysfunction or aphasia; tumours and bleeding
disorders; serious illnesses of the heart, liver, or kidney, or
other severe diseases; pregnant or breastfeeding women;
other disorders that may interfere with completion of
the study.Recruitment procedures
Participants will be recruited in outpatient clinics of
hospitals or community hospitals. Participants will also
be recruited through local newspaper and the hospital
website (http://www.tjh.com.cn/). Doctors from gastro-
intestinal surgery and gastroenterology department of the
local hospitals would be invited to screen participants.
Interventions
Electro-acupuncture (EA) group
The acupuncture treatment bases on traditional Chinese
medicine theory and should be operated by licensed acu-
puncturists. The acupoints are Quchi (LI11) and Shangjuxu
(ST37), which are He-Sea and Lower He-Sea acupoints of
Large Intestine meridians. Both points were considered
as the positive points to treat internal organ’s disease
in traditional Chinese medicine (TCM) and were very
commonly used in FC patients. Sterile, disposable acu-
puncture (0.25 mm in diameter and 40 mm in length) are
used in this trial, which are purchased from DongBang
AcuPrime. Ltd. Co (Marsh Barton, Exeter, UK). In this
group, the fixed points will be inserted bilaterally and ver-
tically by filiform needles after sterilizing. A dull needling
sensation (which called de qi include sour, numb, heavy
and aching) will be obtained through lifting, thrusting,
twirling and rotating the needles. And then, an electro-
acupuncture instrument (HANS-200E, Nanjing Jisheng,
made in Jiangsu, China) will connect with each acu-
puncture needle. The stimulation frequency set 2/50Hz
and electric current varies from 0.1 mA to 1.0 mA until
the patients feel comfortable. Each session will last for
30 minutes per day. A total of 16 sessions of acupunc-
ture treatment will perform over a period of 4 weeks.
Five times a week in the first 2 weeks and three times a
week in the last 2 weeks.
Mosapride (M) group
Participants assigned to this group will receive 5 mg
Mosapride Citrate tablet (Dainippon Sumitomo pharma-
ceutical Co.Ltd, Japan) three times a day for 4 weeks
continuously, in the form of an oral capsule adminis-
tered at least 30 minutes before eating.
Mosapride & Sham Electro-acupuncture (MS) group
The participants appointed to mosapride & sham acupunc-
ture group will be treated with sham acupuncture while
orally given Mosapride Citrate tablets (Dainippon Sumitomo
pharmaceutical Co.Ltd, Japan). The dose of mosapride is
5 mg three times a day for 4 weeks continuously as the
same as mosapride (M) group. In the sham acupuncture
intervention, Park sham devices (PSD) [9] are used, which
are purchased from DongBang AcuPrime. Ltd. Co (Marsh
Barton, Exeter, UK). It is a non-penetrating needle device
with a blunt and retractable needle, a guide tube and a self
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(LI11) and Shangjuxu (ST37), which are also the same
as the treatment group. A precut guide tube which is
fixed by a self adhesive pad was slightly depressed down
onto the selected point. And then, the blunt sham nee-
dle is carefully placed into the guide tube. When
pressed, it telescopes into the handle and induces a
pricking sensation rather than penetrates the skin. Dur-
ing this process, no twirling lifting and thrusting manipula-
tion is conducted. The sham electro-acupuncture
instrument is applied to the needles but the metal inside
the wire has been cut off. We set a stimulation frequency
of 2/50 Hz and electric current of 0.3 mA but actually,
there is no current output and the participants will
never know.
Outcome measures
The primary outcomes of the study is the times of
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Reasons of drop-outs or withdrawals
Patient’s compliance
SF-36, MOS item Short Form health survey; SAS, Self-Rating Anxiety Scale; SDS, Self-
of life questionnaire.8th week after randomization. Secondary efficacy end
points include: 1) stool consistency [10]; 2) intensity of
defecating difficulty; 3) MOS item Short Form health
survey (SF-36) [11]; 4) Self-Rating Anxiety Scale (SAS)
[12]; 5) Self-rating Depression Scale (SDS) [13]; 6) the
validated Patient Assessment of Constipation Quality of
Life (PAC-QOL) [14] (Table 1).
The first three outcomes will be measured at the other
time points (baseline and 2, 4, 8 weeks after randomization)
according to the daily records written by participants.
Stool consistency was assessed by the Bristol Stool
Form Scale (BSFS) [10]. Intensity of defecating diffi-
culty was assessed by a 4-point scale with the following
responses: 0 indicates not at all, 1 a little bit, 2 a moder-
ate amount, 3 a great deal and an extreme amount.
PAC-QOL include 28 items related to the effects of
constipation on daily lives. These outcomes will be mea-
sured at baseline and 2, 4, 8 weeks after randomization
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and 2 and 4 weeks after randomization. SF-36 question-
naire is completed before randomization and 4 weeks
after randomization.
Before randomization all patients will receive routine
tests of urine, stool, blood biochemical (ALT, AST, BUN,
and Scr), electrocardiogram (ECG), and colonoscopy to
exclude these patients who have other severe diseases.
Urine HCG or blood β-HCG will also be tested to exclude
possible pregnant women. These routine tests should also
be done after accomplishment of intervention to help us
assess the adverse events.
Adverse events including bleeding, hematoma, faint-
ing, serious pain, and local infection should be recorded
and resolved immediately during all duration of this
study. Serious adverse events will be documented and
immediately reported to the principal investigator.
Sample size calculation
Sample size was determined based on a study [15] where
the average defecation rate of patients with functional
constipation was 2.6 times per week with a standard
deviation of 2.2 after drug treatment, and a 1.4-fold dif-
ference in the clinical effects between the drug and the
placebo is considered to be of clinical relevance. In this
study, we anticipated that an improvement of the mean
defecating frequency is 4.0 after acupuncture treatment,
with a standard deviation of 3. To detect this difference,
we need a sample size of 71 in each group (α = 0.05,
β = 0.10) [16]. To allow 15% for loss to follow up, our pro-
posed trial requires 243 patients (81 for each group).
Statistical analysis
Statistical analysis of all data will be done by the Depart-
ment of Epidemiology and Biostatistics, School of Public
Health, Tongji Medical College, Huazhong University of
Science and Technology, which is blinded to this trial.
SPSS 17.0 software packages will be used to analyze the
data. All data are provided as mean ± standard deviation
(SD) in continuous data and as frequency/percentage in
categorical data. All of the analyses will be based on both
an intention-to-treat analysis (ITT) and a treated-per-
protocol analysis (TPP). The intention-to-treat (ITT)
population was defined as the patients who are random-
ized and received at least one treatment session. The
missing data will be dealt with the last observation value
carried forward (LOCF) method. The per-protocol (PP)
population was defined as the patients who have no
major protocol violations in the ITT set. Both results of
analysis will be compared to check whether the results
are consistent.
Comparisons among baseline characteristics in different
groups will be analyzed at first by analysis of variance,
Chi-square test, and others. Then analysis will be appliedto compare the effects of intervention between groups.
Chi-square test will be used for comparison of cate-
gorical variables and analysis of variance of repeated
measures will be performed for continuous parameters
between the groups. The level of significance was set a
P value less than 0.05.
Quality control
In order to guarantee the quality of trial, all acupunc-
turists are asked to attend special training. The train-
ing includes how to fill in the case report form, how to
manipulate both true and sham needles, how to teach
the patients to take Mosapride Citrate tablets, and
other details of this trial. A special training test will be
given to the acupuncturists to ensure their under-
standing of protocol. After passing the test they are
qualified to perform this trial. Only acupuncturists
will know the grouping scheme and all the researchers
are forbidden to alter the assignment. Inspectors from
the central structure of the study will check each
research center monthly and report to the investigator.
Reasons and details of drop-outs or withdrawals will be
documented.
Discussions
According to TCM theory, the body was regarded as a
whole composed of internal and external organs. These
organs connected with each other by special ways
called meridians, in which “qi” and “blood” is circulat-
ing. Disease is a state that “qi” and “blood” is deviated
from balance. Functional constipation could be attrib-
uted to "defecation difficulty" in traditional Chinese
Medicine (TCM), which were considered to be caused
by improper diet, emotional disturbance, and invasion of
exogenous pathogen. According to the different patho-
genic factors, "defecation difficulty" could be classified into
the categories of "Qi-deficiency constipation", "Blood-defi-
ciency constipation", "Yin-deficiency constipation", and
"Qi-deficiency constipation" etc. These disturbances at-
tributed to dysfunction of large intestinal transit func-
tion and insufficient large intestinal liquid.
Chinese medicines, acupuncture and moxibustion as
effective complementary and alternative medicine (CAM)
have been widely used to treat FC in China and clinically
adopted in the western world [17]. Acupuncture has been
believed to treat FC at least 3000 years. Some studies have
indicated that acupuncture can play a therapeutic role in
Functional gastrointestinal (GI) symptoms through alter
acid secretion, GI motility, and visceral pain [18-21]. How-
ever, the literature which has been made to investigate the
efficacy of acupuncture on function constipation is scarce.
Some pilot studies reported that acupuncture could im-
prove symptoms of constipation but did not set a control
group [22,23]. In another study, acupuncture has been
Xu et al. BMC Complementary and Alternative Medicine 2014, 14:423 Page 6 of 7
http://www.biomedcentral.com/1472-6882/14/423found to increase the frequency of bowel movement in 17
children with chronic constipation during a 10-week
treatment period but not include adult patients [24].
Based on the current evidences from clinical trials, acu-
puncture seems show potential for treating constipa-
tion. However, this deduction is insufficient and may
lead to bias because the poor quality without a stan-
dardized acupuncture protocol. Therefore we designed
a multicenter randomized controlled protocol and ex-
pected to provide convincing evidence to clarify the
efficacy of acupuncture for treating FC.
Acupoints selected in this trial were Quchi (LI11) and
Shangjuxu (ST37), which were He-Sea and Lower He-Sea
points of Large Intestine meridians. According to trad-
itional acupuncture theories, both of them have a positive
therapeutic effect in treating internal organ disease.
Differing from the other studies adopted non-acupoints
in placebo control, we will use a validated placebo need-
ling [9] and special electrode lines with no current
output at the same acupoints to mimic as closely as pos-
sible the real situation on patients. In the other hand, to
avoid communication with each other, patients will be
assigned to acupuncture treatments alone at different
times. In addition, we will use mosapride as a positive
control group because it has been confirmed as an
effective drug to treat FC in China and western coun-
tries. The primary outcome assessment will be collected
from the diaries which will be convenient and easy for
patients to record. Certainly, the safety of interventions
is needed to consider during the whole process.
As far as we know, this is the first acupuncture trial
adopting sham EA combined with mosapride (MS) as a
control to observe the efficacy of acupuncture for treat-
ing FC. The reasons we selected mosapride & sham
acupuncture as a control instead of simple placebo acu-
puncture based on: Firstly, it will help to improve ther-
apy compliance and reduce the rate of drop-out so
as to ensure that the study is completed smoothly, be-
cause a big part of patients expect to receive acupunc-
ture treatment when they participate in this trial.
Second, whether simple placebo acupuncture is effect-
ive for patients with functional constipation is con-
troversial, so it accords with the ethical principles of
beneficence and justice to avoid ethical confusion.
However, some limitations we must also recognize
that patients are not blinded in this trial. The partici-
pants will know whether they receive acupuncture or
medication although they will not know true or sham
acupuncture they will receive. And then, the physio-
logical effects may be amplified when patients have
a higher positive beliefs and expectations of benefit of
acupuncture compared with medicine, which will
impact the acupuncture effect. These factors will lead to
a bias of the outcome assessment. In conclusion, thestudy will supply significant evidence for using acu-
puncture to treat FC, and help us to observe whether it
is a therapeutic effect rather than a placebo effect.
Trial status
This trial is currently recruiting participants. The first
participant was included on 20 March 2012 and the
investigators are still collecting.
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